
WB analysis of EL4 cell lysate using GTX85160 NOD4 antibody. Working concentration : 1 microg/ml
NOD4 antibody
GTX85160
ApplicationsImmunoFluorescence, Western Blot, ELISA, ImmunoCytoChemistry
Product group Antibodies
TargetNLRC5
Overview
- SupplierGeneTex
- Product NameNOD4 antibody
- Delivery Days Customer9
- Application Supplier NoteWB: 1 microg/mL. ICC/IF: 10 microg/mL. *Optimal dilutions/concentrations should be determined by the researcher.Not tested in other applications.
- ApplicationsImmunoFluorescence, Western Blot, ELISA, ImmunoCytoChemistry
- CertificationResearch Use Only
- ClonalityPolyclonal
- Concentration1 mg/ml
- ConjugateUnconjugated
- Gene ID84166
- Target nameNLRC5
- Target descriptionNLR family CARD domain containing 5
- Target synonymsCLR16.1, NOD27, NOD4, protein NLRC5, NOD-like receptor C5, caterpiller protein 16.1, nucleotide-binding oligomerization domain protein 4, nucleotide-binding oligomerization domain, leucine rich repeat and CARD domain containing 5, nucleotide-binding oligomerization domains 27
- HostRabbit
- IsotypeIgG
- Protein IDQ86WI3
- Protein NameProtein NLRC5
- Scientific DescriptionNOD4 is a member of the NOD (nucleotide-binding oligomerization domain) family, a group of proteins that are involved in innate immune defense. NOD4 contains a CARD-like domain, a central NOD domain and a large LRR region. NOD4, an IFN-gamma-inducible nuclear protein, plays a role in homeostatic control of innate immunity and in antiviral defense mechanisms. As a key negative regulator of NF-ases, including cancer.
- Storage Instruction-20°C or -80°C,2°C to 8°C
- UNSPSC12352203
References
- Liang S, Xiang T, Liu S, et al. Inhibition of NLRC5 attenuates the malignant growth and enhances the sensitivity of gastric cancer cells to 5-FU chemotherapy by blocking the carcinogenic effect of YY1. Exp Ther Med. 2022,24(3):601. doi: 10.3892/etm.2022.11538Read this paper






